tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Michael Petusky, 201 are a BUY (88.94%), 23 are a HOLD (10.18%), 2 are a SELL (0.88%).
Analyst Michael Petusky, currently employed at BARRINGTON, carries an average stock price target met ratio of 59.06% that have a potential upside of 25.39% achieved within 269 days.
Michael Petusky’s has documented 545 price targets and ratings displayed on 18 stocks. The coverage is on Healthcare, Consumer Defensive, Technology sectors.
Most recent stock forecast was given on ANIK, Anika Therapeutics at 12-May-2025.
Analyst best performing recommendations are on VRME (VERIFYME).
The best stock recommendation documented was for VRME (VERIFYME) at 3/29/2023. The price target of $2 was fulfilled within 5 days with a profit of $0.43 (27.39%) receiving and performance score of 54.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$19
$8.41 (79.41%)
$20
1 months 15 days ago
(12-May-2025)
10/17 (58.82%)
$7.15 (60.34%)
110
Buy
$32
$21.41 (202.17%)
$61
1 years 10 months 18 days ago
(09-Aug-2023)
1/3 (33.33%)
$11.99 (59.92%)
73
Hold
$35
2 years 8 months 13 days ago
(14-Oct-2022)
0/2 (0%)
$8.78 (33.49%)
Hold
$46
$23.44 (103.90%)
$46
3 years 7 months 9 days ago
(18-Nov-2021)
0/2 (0%)
$5.44 (13.41%)
Buy
$65
$54.41 (513.79%)
$54
5 years 5 months 17 days ago
(10-Jan-2020)
5/6 (83.33%)
$15.2 (30.52%)
21
Which stock is Michael Petusky is most bullish on?
Which stock is Michael Petusky is most reserved on?
What Year was the first public recommendation made by Michael Petusky?
